Farrell Michael J.'s Form 4 filing
Resmed Inc (RMD) · filed Nov 27, 2024
- Accession no.
- 0001127602-24-028165
- Filed
- Nov 27, 2024
- Trade date
- Nov 25-27, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $499.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Farrell Michael J.CIK 0001485164 | Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 27, 2024 | ResMed Common Stock | GGiftDisposed | −2,000 | $0.00 | $0 | 2,090 | Indirect | |
| Nov 27, 2024 | ResMed Common Stock | GGiftAcquired | +2,000 | $0.00 | $0 | 2,000 | Indirect | |
| Nov 27, 2024 | ResMed Common Stock | SSaleDisposed | −2,000 | $249.67 | −$499,340 | 0 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | ResMed Common Stock | AGrant or awardAcquired | +33,036 | $249.56 | +$8,244,464.16 | 33,036 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.